COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old

NCT03268109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 281

Last updated 2025-06-25

No results posted yet for this study

Summary

Despite combined antiretroviral therapy (cART), milder forms of HIV-associated neurocognitive disorders (HAND) persist in 20-50% of persons living with HIV (PLHIV). Since more PLH are at risk for HAND due to aging, the frequency of HAND in PLHIV ≥ 65 years old is important to quantify for planning early intervention to attenuate both functional and occupational disabilities due to cognitive impairment.

Conditions

Interventions

OTHER

assessment of cognitive impairment

Measure of Global Deficit Score

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Principal Investigators

  • Antoine Moulignier, MD · Fondation Ophtalmologique A. de Rothschild

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-22
Primary Completion
2025-05-12
Completion
2025-05-12

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03268109 on ClinicalTrials.gov